Satellos Bioscience 

$7.36
0
+$0.19+2.65% Wednesday 19:53

Statistics

Day High
7.55
Day Low
7.01
52W High
13.4
52W Low
4.52
Volume
18,934
Avg. Volume
78,532
Mkt Cap
1.36B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

2JunExpected
Q3 2025
Q4 2025
Next
-0.51
-0.45
-0.39
-0.33
Expected EPS
-0.4869820296
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-39.99MNet Income

Analyst Ratings

15.5Average Price Target
The highest estimate is 20.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MSLE. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Satellos Bioscience, Inc. is a regenerative medicine company, which engages in developing novel therapeutics. It operates through a proprietary technology platform, MyoReGenX™ and Leveraging MyoReGenX™, which identify stem cell based regeneration deficits in muscle diseases and develop therapeutic solutions. The company was founded by Frank Gleeson and Michael Rudnicki on July 27, 2012 and is headquartered in Toronto, Canada.
Show more...
CEO
Mr. Francis Gleeson B.B.A. M.B.A
Employees
14
Country
Canada
ISIN
CA80401L8033

Listings

0 Comments

Share your thoughts

FAQ

What is Satellos Bioscience stock price today?
The current price of MSLE is $7.36 USD — it has increased by +2.65% in the past 24 hours. Watch Satellos Bioscience stock price performance more closely on the chart.
What is Satellos Bioscience stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Satellos Bioscience stocks are traded under the ticker MSLE.
What is Satellos Bioscience market cap?
Today Satellos Bioscience has the market capitalization of 1.36B
When is the next Satellos Bioscience earnings date?
Satellos Bioscience is going to release the next earnings report on June 02, 2026.
What were Satellos Bioscience earnings last quarter?
MSLE earnings for the last quarter are -0.51 USD per share, whereas the estimation was -0.38 USD resulting in a -34.21% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Satellos Bioscience revenue for the last year?
Satellos Bioscience revenue for the last year amounts to 0 USD.
What is Satellos Bioscience net income for the last year?
MSLE net income for the last year is -39.99M USD.
How many employees does Satellos Bioscience have?
As of April 16, 2026, the company has 14 employees.
In which sector is Satellos Bioscience located?
Satellos Bioscience operates in the Other sector.
When did Satellos Bioscience complete a stock split?
Satellos Bioscience has not had any recent stock splits.
Where is Satellos Bioscience headquartered?
Satellos Bioscience is headquartered in Toronto, Canada.